Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xinming Su

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
Nature Communications|March 30, 2018
Breast and pancreatic cancer interrupt IRF8-dependent dendritic cell development to overcome immune surveillanceMelissa A Meyer, John M Baer, Brett L Knolhoff, et al.
Plos One|December 20, 2023
Transferrin receptor in primary and metastatic breast cancer: Evaluation of expression and experimental modulation to improve molecular targetingFrancesca Fontana, Alison K Esser, Christopher Egbulefu, et al.
Cell Reports|January 4, 2016
Stromal-Initiated Changes in the Bone Promote Metastatic Niche DevelopmentXianmin Luo, Yujie Fu, Andrew J Loza, et al.
Cancer Research|August 11, 2018
Inhibition of the Stromal p38MAPK/MK2 Pathway Limits Breast Cancer Metastases and Chemotherapy-Induced Bone LossBhavna Murali, Qihao Ren, Xianmin Luo, et al.
Journal of Virology|March 23, 2022
Heparanase Blockade as a Novel Dual-Targeting Therapy for COVID-19Jingyu Xiang, Mijia Lu, Min Shi, et al.
Journal of Bone Oncology|May 7, 2026
CDK4/6 inhibitor ribociclib and doxorubicin combination treatment inhibits breast cancer bone metastasis and enhances T-cell targeted therapyXinming Su, Takayuki Kobayashi, Jingyu Xiang, et al.
Research Square|April 1, 2024
Induction of complementary immunogenic necroptosis and apoptosis cell death pathways inhibits cancer metastasis and relapseChristopher Egbulefu, Kvar Black, Xinming Su, et al.
Molecular Cancer Therapeutics|August 14, 2015
CXCR4 Protein Epitope Mimetic Antagonist POL5551 Disrupts Metastasis and Enhances Chemotherapy Effect in Triple-Negative Breast CancerJingyu Xiang, Michelle A Hurchla, Francesca Fontana, et al.
Communications Biology|January 19, 2026
Radionuclide-stimulated dynamic therapy induces complementary immunogenic necroptosis and apoptosis cancer cell death pathwaysChristopher Egbulefu, Kvar Black, Xinming Su, et al.
JCI Insight|October 4, 2019
HTLV-1 viral oncogene HBZ drives bone destruction in adult T cell leukemiaJingyu Xiang, Daniel A Rauch, Devra D Huey, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Nature Communications|March 30, 2018
Breast and pancreatic cancer interrupt IRF8-dependent dendritic cell development to overcome immune surveillanceMelissa A Meyer, John M Baer, Brett L Knolhoff, et al.
Plos One|December 20, 2023
Transferrin receptor in primary and metastatic breast cancer: Evaluation of expression and experimental modulation to improve molecular targetingFrancesca Fontana, Alison K Esser, Christopher Egbulefu, et al.
Cell Reports|January 4, 2016
Stromal-Initiated Changes in the Bone Promote Metastatic Niche DevelopmentXianmin Luo, Yujie Fu, Andrew J Loza, et al.
Cancer Research|August 11, 2018
Inhibition of the Stromal p38MAPK/MK2 Pathway Limits Breast Cancer Metastases and Chemotherapy-Induced Bone LossBhavna Murali, Qihao Ren, Xianmin Luo, et al.
Journal of Virology|March 23, 2022
Heparanase Blockade as a Novel Dual-Targeting Therapy for COVID-19Jingyu Xiang, Mijia Lu, Min Shi, et al.
Journal of Bone Oncology|May 7, 2026
CDK4/6 inhibitor ribociclib and doxorubicin combination treatment inhibits breast cancer bone metastasis and enhances T-cell targeted therapyXinming Su, Takayuki Kobayashi, Jingyu Xiang, et al.
Research Square|April 1, 2024
Induction of complementary immunogenic necroptosis and apoptosis cell death pathways inhibits cancer metastasis and relapseChristopher Egbulefu, Kvar Black, Xinming Su, et al.
Molecular Cancer Therapeutics|August 14, 2015
CXCR4 Protein Epitope Mimetic Antagonist POL5551 Disrupts Metastasis and Enhances Chemotherapy Effect in Triple-Negative Breast CancerJingyu Xiang, Michelle A Hurchla, Francesca Fontana, et al.
Communications Biology|January 19, 2026
Radionuclide-stimulated dynamic therapy induces complementary immunogenic necroptosis and apoptosis cancer cell death pathwaysChristopher Egbulefu, Kvar Black, Xinming Su, et al.
JCI Insight|October 4, 2019
HTLV-1 viral oncogene HBZ drives bone destruction in adult T cell leukemiaJingyu Xiang, Daniel A Rauch, Devra D Huey, et al.
Pageof 7